Total Payments
$140,365
2024 Payments
$42,364
Companies
29
Transactions
131
Medicare Patients
1,005
Medicare Billing
$160,598
Payment Breakdown by Category
Consulting$79,236 (56.5%)
Other$50,457 (35.9%)
Travel$6,569 (4.7%)
Food & Beverage$4,084 (2.9%)
Education$18.60 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $79,236 | 40 | 56.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,402 | 13 | 29.5% |
| Honoraria | $9,055 | 4 | 6.5% |
| Travel and Lodging | $6,569 | 23 | 4.7% |
| Food and Beverage | $4,084 | 50 | 2.9% |
| Education | $18.60 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Acrotech Biopharma Inc. | $38,313 | 25 | $0 (2024) |
| Seagen Inc. | $22,894 | 16 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $13,306 | 22 | $0 (2018) |
| PFIZER INC. | $10,519 | 6 | $0 (2024) |
| Epizyme, Inc., | $9,997 | 9 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $8,766 | 2 | $0 (2022) |
| Incyte Corporation | $6,960 | 3 | $0 (2024) |
| MorphoSys, US Inc. | $5,117 | 5 | $0 (2022) |
| Seattle Genetics, Inc. | $4,481 | 7 | $0 (2019) |
| GENZYME CORPORATION | $4,314 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42,364 | 24 | Acrotech Biopharma Inc. ($21,770) |
| 2023 | $25,203 | 21 | Acrotech Biopharma Inc. ($10,302) |
| 2022 | $37,181 | 35 | Seagen Inc. ($9,931) |
| 2021 | $11,758 | 14 | Epizyme, Inc., ($3,540) |
| 2020 | $5,708 | 3 | GENZYME CORPORATION ($4,314) |
| 2019 | $4,602 | 9 | Seattle Genetics, Inc. ($4,481) |
| 2018 | $13,383 | 23 | Bayer HealthCare Pharmaceuticals Inc. ($13,306) |
| 2017 | $166.20 | 2 | Pharmacyclics LLC, An AbbVie Company ($108.20) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Ipsen Bioscience Inc. | — | Consulting Fee | Cash or cash equivalent | $1,040.00 | General |
| 10/17/2024 | Incyte Corporation | MONJUVI (Drug) | Consulting Fee | Cash or cash equivalent | $4,795.00 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Ipsen Bioscience Inc. | — | Consulting Fee | Cash or cash equivalent | $870.00 | General |
| 08/02/2024 | Ipsen Bioscience Inc. | — | Consulting Fee | Cash or cash equivalent | $1,305.00 | General |
| 07/26/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 06/07/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $115.45 | General |
| Category: Monoclonal Antibody | ||||||
| 05/21/2024 | PFIZER INC. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: Oncology | ||||||
| 05/21/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $116.42 | General |
| Category: Oncology | ||||||
| 05/15/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2024 | PFIZER INC. | ADCETRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,600.00 | General |
| Category: Oncology | ||||||
| 05/09/2024 | PFIZER INC. | ADCETRIS (Biological) | Travel and Lodging | In-kind items and services | $268.00 | General |
| Category: Oncology | ||||||
| 05/09/2024 | PFIZER INC. | ADCETRIS (Biological) | Travel and Lodging | In-kind items and services | $232.68 | General |
| Category: Oncology | ||||||
| 05/09/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $102.00 | General |
| Category: Oncology | ||||||
| 05/03/2024 | Acrotech Biopharma Inc. | — | Consulting Fee | Cash or cash equivalent | $3,657.57 | General |
| 05/02/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,700.00 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,047.00 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,700.00 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $990.05 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 02/08/2024 | BeiGene, Ltd. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Oncology | ||||||
| 01/12/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 01/03/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 12/11/2023 | Ipsen Biopharmaceuticals, Inc | Tazverik (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 221 | 284 | $73,314 | $31,980 |
| 2022 | 5 | 271 | 423 | $89,865 | $39,352 |
| 2021 | 5 | 293 | 516 | $102,514 | $48,028 |
| 2020 | 5 | 220 | 450 | $102,002 | $41,238 |
Total Patients
1,005
Total Services
1,673
Medicare Billing
$160,598
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 80 | 129 | $30,934 | $14,729 | 47.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 90 | 90 | $30,870 | $12,801 | 41.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 51 | 65 | $11,510 | $4,450 | 38.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 102 | 150 | $34,014 | $16,817 | 49.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 77 | 77 | $25,142 | $10,863 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 60 | 83 | $14,007 | $5,584 | 39.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 102 | $15,096 | $5,574 | 36.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 11 | 11 | $1,606 | $514.89 | 32.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 110 | 189 | $40,725 | $21,595 | 53.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 73 | 73 | $23,725 | $10,287 | 43.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 145 | $21,460 | $8,401 | 39.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 64 | 90 | $13,830 | $6,644 | 48.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 19 | 19 | $2,774 | $1,100 | 39.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 109 | 272 | $58,480 | $23,731 | 40.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 65 | 65 | $21,125 | $8,493 | 40.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 78 | $16,536 | $6,748 | 40.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 22 | 24 | $3,672 | $1,326 | 36.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 11 | 11 | $2,189 | $939.12 | 42.9% |
About Dr. Hayder Saeed, M.D
Dr. Hayder Saeed, M.D is a Hematology & Oncology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2010. The National Provider Identifier (NPI) number assigned to this provider is 1851619118.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hayder Saeed, M.D has received a total of $140,365 in payments from pharmaceutical and medical device companies, with $42,364 received in 2024. These payments were reported across 131 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($79,236).
As a Medicare-enrolled provider, Saeed has provided services to 1,005 Medicare beneficiaries, totaling 1,673 services with total Medicare billing of $160,598. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Tampa, FL
- Active Since 05/12/2010
- Last Updated 08/06/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1851619118
Products in Payments
- ADCETRIS (Biological) $37,654
- BELEODAQ (Drug) $34,655
- Aliqopa (Drug) $13,306
- TAZVERIK (Drug) $9,997
- MONJUVI (Drug) $9,912
- ELITEK (Biological) $4,314
- FARYDAK (Drug) $2,571
- UKONIQ (Drug) $2,025
- BRUKINSA (Drug) $423.42
- Tazverik (Drug) $232.45
- CALQUENCE (Drug) $192.28
- Epkinly (Drug) $163.93
- IMBRUVICA (Drug) $128.58
- Copiktra (Drug) $121.24
- Poteligeo (Drug) $115.45
- Imbruvica (Drug) $108.20
- VENCLEXTA (Biological) $93.44
- VYXEOS (Drug) $77.69
- OPDIVO (Biological) $58.00
- GAMIFANT (Drug) $18.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Tampa
Damian Laber, Md, MD
Hematology & Oncology — Payments: $1.4M
Hematology & Oncology $1.4M
Eduardo Sotomayor, Md, MD
Hematology & Oncology — Payments: $447,992
Hematology & Oncology $447,992
Ariel Grajales-Cruz
Hematology & Oncology — Payments: $424,303
Hematology & Oncology $424,303
Dr. Kendra Sweet, M.d, M.D
Hematology & Oncology — Payments: $215,309
Hematology & Oncology $215,309
Khaldoun Almhanna, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $173,538
Hematology & Oncology $173,538
Dr. Hatem Soliman, Md, MD
Hematology & Oncology — Payments: $138,958
Hematology & Oncology $138,958